Filling the need for trusted information on national health issues…

Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

PLOS Medicine Announces Special Issue On Climate Change, Health, Calls For Research Submissions

PLOS Blogs’ “Speaking of Medicine”: PLOS Medicine Special Issue: Climate change and health “…The editors of PLOS Medicine, together with Guest Editors Jonathan Patz, Global Health Institute, University of Wisconsin-Madison, and Madeleine Thomson, International Research Institute for Climate and Society, Columbia University, are pleased to announce a special issue on…

Universal Flu Vaccine Could Prevent Widespread Epidemic, Researchers Say

Global Health NOW: U.S., World Still Not Ready for Another Flu Pandemic “Despite countless breakthroughs in medicine since the 1918 flu pandemic, one key advance continues to elude researchers. Without a universal vaccine to combat ever-changing flu strains, another pandemic threatens to overwhelm U.S. health care system, warns Tom Inglesby,…

Nearly All Cholera Epidemics Originate In Asia, Bacterial Genome Studies Show

Science: Asia is the cradle of almost every cholera epidemic, genome studies show “…By sequencing and comparing hundreds of bacterial genomes, [scientists] have shown that all of the explosive epidemics of cholera in Africa and the Americas in the past half-century arose after the arrival of new strains that had…

Increasing Availability Of Essential Medicines Critical To Global Health Security

Project Syndicate: How to Boost Access to Essential Medicines Justus Haucap, professor of economics at Heinrich-Heine University “…[L]ow- and middle-income countries … need help improving drug delivery and managing chronic diseases such as cancer and diabetes, which impose an immense burden on their economies. … Unfortunately, the WHO’s leadership, like…

Repurposing Existing Products Could Speed Up Drug, Vaccine Development

STAT: How to speed up drug and vaccine development during a public health crisis Michelle L. Rose, principal consultant, and Claudia K. Fehling consultant, both with Halloran Consulting Group “…The entire process [of drug and vaccine development], from basic research to Food and Drug Administration approval, averages about 10 years…

Though Investment In TB R&D Increased In 2016, Funding Represents One-Third Of Need, Report Says

Center for Global Health Policy’s “Science Speaks”: TB R&D spending climbs — but not enough Antigone Barton, senior editor and writer of “Science Speaks,” discusses a Treatment Action Group report that found “[i]nvestment in research and development toward new tuberculosis drugs, diagnostic tests, and preventive measures increased in 2016 for the first…

Ebola Data Platform Should Be African-Based, Led Effort

Nature: Build the Ebola database in Africa Brian Conton, clinical director of the Physio-Fitness Rehabilitation Centre in Sierra Leone “…This September, the Infectious Diseases Data Observatory (IDDO), a research network based at the University of Oxford, U.K., held a meeting in Guinea to discuss plans for an information platform to…

U.S. Should Strengthen Investments In Global Health R&D

The Hill: Let’s tackle new health threats before they reach us Mark Dybul, professor of medicine at the Georgetown University Medical Center, former executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, and former U.S. Global HIV/AIDS Coordinator “…The need for research to develop new drugs, vaccines,…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.